EP Patent

EP3144299A1 — Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis

Assigned to Northwestern University · Expires 2017-03-22 · 9y expired

What this patent protects

The present invention relates to the identification of inventive pyrimidine-2,4,6- triones (PYT compounds) of formula (I) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention als…

USPTO Abstract

The present invention relates to the identification of inventive pyrimidine-2,4,6- triones (PYT compounds) of formula (I) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the inventive PYT compounds.

Drugs covered by this patent

Patent Metadata

Patent number
EP3144299A1
Jurisdiction
EP
Classification
—
Expires
2017-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Northwestern University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.